As more and more companies embrace partnering as the key means to fill their pipelines, winning the race to access the most innovative new molecules and therapies is only becoming more and more competitive. Relying on a world-class position in a therapeutic area is no longer enough – because in the partnering game second place isn’t good enough. Getting a partnership deal signed requires a best-in-class Business Development capability – but what does that mean, and how does an organization evaluate whether they have one? This presentation will review:
• What a BD capability that is built to win “looks like” – what do the best-in-class organizations do?
• What steps an organization might take to benchmark where it stands against the competition
• How an organization can identify gaps based on the above assessment and develop recommendations to fill them